DTX +
DTX +, licence 80038324: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Natures Harmony DTX Factors+, Quest DTX Factors+, RX Balance DTX Factors+, Vivitas DTX Factors+
- Licence holder
- RX BALANCE TECHNOLOGY INC.
- NPN or DIN-HM
- 80038324
- Status
- Active licence
- Licence date
- 16 December 2012
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Manganèse: up to 6.4 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 3.5 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Sélénium: up to 133.2 µg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one | 33.3 mg | Not calculated |
| Riboflavine Source : Riboflavine-5-phosphate | 4.1 mg | 16,400 µg |
| Manganèse Source : Citrate de manganèse | 1.6 mg | 6,400 µg |
| Magnésium Source : Citrate de magnésium | 32.1 mg | 128,400 µg |
| Molybdène Source : Molybdate de sodium | 16.0 mcg | 64 µg |
| Choline Source : Bitartrate de choline | 33.3 mg | Not calculated |
| Thiamine Source : Chlorhydrate de thiamine | 2.5 mg | 10,000 µg |
| myo-inositol, Hexa-3-pyridinecarboxylate Potency : 15.0 mg Niacin | 19.3 mg | Not calculated |
| Bêta-carotène Source : Bêta carotène Potency : 1250.0 UI | 750.0 mcg | Not calculated |
| Acide pantothénique Source : D-pantothénate de calcium | 16.6 mg | 66,400 µg |
| acide (S)-alpha-amino-1H-imidazole-4-propanoïque Source : Chlorhydrate de L-histidine | 8.3 mg | Not calculated |
| Vitis vinifera Source : Graine(s) Potency : 95.0 % Proanthocyanidin | 1.6 mg | Not calculated |
| Sélénium Source : Sélénométhionine | 33.3 mcg | 133.2 µg |
| Brassica oleracea Source : Florets Extraction ratio : 20:1 Dry plant equivalent : 332 mg | 16.6 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Multi ingredient complex to help support the body's detoxification systems, to reduce oxidative stress, and to help maintain good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80038324
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.